-
The pharmaceutical company announced on the same day that 3 new drugs were approved for clinical trials!
Time of Update: 2022-11-25
js?cdnversion='+~(-new Date()/36e5)];At present, a large number of pharmaceutical companies are actively responding to national policies, constantly adapting to the higher requirements brought by industrial changes, and continuing to steadily promote scientific and technological innovation.
-
Issue 3 2021 - Total invests in the acquisition of shares in renewable energy companies in India
Time of Update: 2022-11-12
5 billion to acquire a stake in Indian renewable energy company Adani Green Energy Ltd (AGEL) and a portfolio of solar energy assets, marking the company's latest move to reduce its dependence on oil.
-
Institutional research 3 pharmaceutical and biological companies have been surveyed by more than 100 institutions
Time of Update: 2022-10-31
【Pharmaceutical Network Industry News】In the past 5 days (October 18 to October 24), the institutional research stock shows that a total of 51 companies have been investigated by institutions, of which 8 are pharmaceutical and biological companies, namely Junshi Biologics, Walt Dyne, Propharmaceutical, Kai Medical, Poinsettia, Weili Medical, OPCOM Vision, and Zhenghai Biotechnology.
-
1.5 billion cefixime drugs have welcomed 3 more pharmaceutical companies to pass the evaluation
Time of Update: 2022-10-31
Among them, 19 companies have production approvals for cefixime tablets, and the currently evaluated enterprises include Jiangsu Zhengda Qingjiang Pharmaceutical, Hunan Sheng Pharmaceutical, Zhejiang Jutai Pharmaceutical and Shenzhen Lijian Pharmaceutical that has recently been evaluated, in addition, Shandong Lukang Pharmaceutical consistency evaluation supplementary application is under review, Wenling Innovative Biomedicine | Wanbangde Pharmaceutical is under review for generic 3 types of production, which is regarded as having been evaluated after approval.
-
Within 3 days, the cooperation of 3.5 billion yuan and 2.2 billion US dollars was officially announced, how did this company do it?
Time of Update: 2022-10-25
With the development of omics technology, information technology, gene technology and in-depth study of disease biology, the rational design, virtual screening, high-throughput synthesis, structural
-
Within a year, 3 deputy general managers of the pharmaceutical company left! In 2021, the pre-tax remuneration will exceed 4 million yuan
Time of Update: 2022-10-19
Among them, Hengrui Pharmaceutical has resigned three deputy general managers since the beginning of the year, namely Tao Weikang, Zou Jianjun and Zhang Yuehong.
Among them, Hengrui Pharmaceutical has resigned three deputy general managers since the beginning of the year, namely Tao Weikang, Zou Jianjun and Zhang Yuehong.
-
The world's most efficient pharmaceutical companies TOP list released! There are only 3
Time of Update: 2022-10-14
Note: The list only counts pharmaceutical companies with revenues of more than $10 billion in 2021; Revenue per capita is revenue for 2021 divided by the total number of employees in the company Data source: References With mRNA COVID-19 vaccine With mRNA COVID-19 vaccine BioNTech/Moderna topped the list BioNTech/Moderna topped the list Three years ago, with the COVID-19 pandemic and the success of the mRNA COVID-19 vaccine, BioNTech and Moderna topped the list of the world's most efficient pharmaceutical companies.
-
Guangzhou a bee industry company advocated that ordinary food has curative effects, and manufacturers were sentenced to 3 times the compensation
Time of Update: 2022-10-04
Yesterday, the Huangpi District Court of Wuhan City concluded a dispute case over the liability of the product seller, found that there was false publicity when the product was sold on the online shopping platform, which constituted fraud, and ordered the product company to compensate the consumer for more than 10,000 yuan of losses at 3 times the purchase price.
-
A paper 3 years ago, a new antiviral company was born, using Cas13 to shred the viral genome
Time of Update: 2022-10-02
The study combined the antiviral activity of Cas13 with its diagnostic capabilities to establish a powerful and rapidly programmable diagnostic and antiviral system, CARVER, that detects and destroys RNA viruses in human cells and could one day be used to diagnose and treat viral infections, including those caused by emerging viruses.
-
Change of deputy general manager of pharmaceutical company: 3 deputy general managers of the company leave within 1 day!
Time of Update: 2022-10-02
In addition, on the evening of July 1, Xinhua Pharmaceutical issued an announcement that Mr. Du Deping applied to resign from all positions of the company's directors, general managers, professional committees under the board of directors and subsidiaries of the company due to job changes.
-
In the next 3-5 years, China's innovative pharmaceutical companies will usher in a big test! How to deal with it?
Time of Update: 2022-09-06
" The industry said that with the increasing cost of innovative research and development and the low return on investment in the single market, the layout of pharmaceutical companies in the international market is a new way out, which is also conducive to enhancing the competitiveness of innovative enterprises.
-
The China Securities Regulatory Commission approves the IPO registration of 3 pharmaceutical
Time of Update: 2022-08-30
, Ltd. Enwei Pharmaceutical plans to raise 700 million yuan to enhance the competitiveness of its main business Enwei Pharmaceutical was established in May 2005, mainly engaged in the research and development, production and sales of Chinese patent medicines and chemical drugs, focusing on gynecological products, pediatric drugs, respiratory system drugs, etc.
-
The pharmaceutical company expects that 3 blockbuster drugs will be approved before the end of the year, and will enter the market for 100 billion yuan!
Time of Update: 2022-08-30
Up to now, the company has a total of 86 pharmaceutical research projects, including 43 innovative drugs and biological drug projects; in addition, canagliflozin tablets, liraglutide injection, and sorafenib tosylate tablets are three major The pound products are expected to be approved before the end of the year, and they will enter the market of 100 billion yuan .
-
On August 15, 3 listed pharmaceutical companies disclosed their performance in the first half of the year, and 2 achieved growth!
Time of Update: 2022-08-19
79% year-on-year According to the 2022 semi-annual report of Chengda Pharmaceutical, the company achieved operating income of 217 million yuan in the first half of the year, a year-on-year increase of 11.
-
A safety accident in a chemical company in Peixian, Jiangsu killed 3 maintenance personnel
Time of Update: 2022-08-12
WeChat public account WeChat public account Global Coatings Network News: On the evening of December 31, 2019, a safety accident occurred in Xuzhou Tianan Chemical Co.
WeChat public account WeChat public account Global Coatings Network News: On the evening of December 31, 2019, a safety accident occurred in Xuzhou Tianan Chemical Co.
